biotechnology – IPPI: The IP Policy Institute

[Archived Post] A View from Both Sides: COVID-19, the TRIPS Waiver, IP Rights, and How to Increase the Supply of Vaccines

Posted on: June 22, 2021May 13, 2026Healthcare , International Law

Issue The United States and other wealthy nations have access to plenty of COVID-19 vaccine doses and thus are beginning to get the pandemic under control, while less affluent countries […]

[Archived Post] How IP-Fueled Innovations in Biotechnology Have Led to the Gene Revolution

Posted on: November 30, 2015May 13, 2026Biotech , Gene Patents , Innovation , Inventors , Uncategorized

We’ve released a new issue paper, The Gene Revolution, by Amanda Maxham, a research associate and writer at the Ayn Rand Institute. Dr. Maxham explores how innovations in biotechnology, enabled […]

[Archived Post] Federal Circuit Threatens Innovation: Dissecting the Ariosa v. Sequenom Opinion

Posted on: June 23, 2015May 13, 2026Biotech , Gene Patents , Innovation , Intellectual Property Theory , Inventors , Patent Law , Patent Litigation , Patent Theory , Patentability Requirements , Supreme Court , Uncategorized

By Patent Publius Earlier this month, the Federal Circuit issued its opinion in Ariosa v. Sequenom, a closely-watched biotechnology case with significant repercussions for patent-eligibility analysis generally. Unfortunately, the Federal […]